about
Alterations in the expression of DEAD-box and other RNA binding proteins during HIV-1 replicationHuman immunodeficiency virus type 1 Vpr-dependent cell cycle arrest through a mitogen-activated protein kinase signal transduction pathwayEffects of HIV-1 Nef on cellular gene expression profilesEffects of HIV-1 nef on cellular gene expression profilesRNA stability regulates human T cell leukemia virus type 1 gene expression in chronically-infected CD4 T cells.The expression of the essential nuclear splicing factor SC35 is altered by human immunodeficiency virus infection.Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine.Glycocalicin levels in the plasma of HIV+ patients: an indicator of platelet turnover.Transcription program of human herpesvirus 8 (kaposi's sarcoma-associated herpesvirus).Differentiation-dependent human immunodeficiency virus long terminal repeat regulatory elements active in human teratocarcinoma cellsSino-orbital-cerebral aspergillosis in immunocompromised pediatric patients.Cell line-dependent variability in HIV activation employing DNMT inhibitorsSuppression of tetradecanoyl phorbol acetate-induced lytic reactivation of Kaposi's sarcoma-associated herpesvirus by K1 signal transductionTwice-daily application of HIV microbicides alter the vaginal microbiota.Single-dose and steady-state pharmacokinetics of tenofovir disoproxil fumarate in human immunodeficiency virus-infected children.Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivatorGene expressions in Jurkat cells poisoned by a sulphur mustard vesicant and the induction of apoptosisCulture-independent evaluation of the appendix and rectum microbiomes in children with and without appendicitis.Cognitive decline with immunologic and virologic stability in four children with human immunodeficiency virus disease.The Oral Bacterial Communities of Children with Well-Controlled HIV Infection and without HIV InfectionApoptosis-induced activation of HIV-1 in latently infected cell linesAn alternative Kaposi's sarcoma-associated herpesvirus replication program triggered by host cell apoptosis.Human immunodeficiency virus type 1 infection of H9 cells induces increased glucose transporter expressionp21(WAF1) gene promoter is epigenetically silenced by CTIP2 and SUV39H1.Isolation and characterization of phagosomes containing Chlamydia psittaci from L cellsIsolation and characterization of macrophage phagosomes containing infectious and heat-inactivated Chlamydia psittaci: two phagosomes with different intracellular behaviors.Attachment defect in mouse fibroblasts (L cells) persistently infected with Chlamydia psittaci.Association between resistance to superinfection and patterns of surface protein labeling in mouse fibroblasts (L cells) persistently infected with Chlamydia psittaci.Virologic response using directly observed therapy in adolescents with HIV: an adherence tool.Replication of type 1 human immunodeficiency viruses containing linker substitution mutations in the -201 to -130 region of the long terminal repeatDecreased bone mineral density with off-label use of tenofovir in children and adolescents infected with human immunodeficiency virus.Linker-scanning mutational analysis of the transcriptional activity of the human immunodeficiency virus type 1 long terminal repeatTargeting IκB proteins for HIV latency activation: the role of individual IκB and NF-κB proteins.Correction for Prasad et al., Activation of Human Herpesvirus Replication by ApoptosisActivation of human herpesvirus replication by apoptosisHost cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency.The human immunodeficiency virus type 1 polyadenylylation signal: a 3' long terminal repeat element upstream of the AAUAAA necessary for efficient polyadenylylationDissection of the Kaposi's sarcoma-associated herpesvirus gene expression program by using the viral DNA replication inhibitor cidofovir.Mechanisms and pathways of congenital infections.Emergence of human immunodeficiency virus type 1 variants containing the Q151M complex in children receiving long-term antiretroviral chemotherapy.
P50
Q21245214-02BCC1B9-5906-4B7F-A204-B815E5F16797Q24530134-5EF6867F-D384-401D-BE0C-00FDC65D9D92Q28216600-F3571A0D-ECF1-4749-A3AD-F9E10FC3A116Q29396306-FDE215F4-2F34-4D6C-ABBF-27B9275EAA6CQ30252424-A6715A80-57B0-44A1-BECF-16A3885B3F22Q32061728-546F2595-5E27-495C-8AED-0AA8A768690FQ32127315-22993282-618C-4936-AA5C-DDACF060569DQ33504095-BCD6B32A-8C7A-4EA8-BDDE-75AA4A44C9CDQ33841257-89BC9BD7-3FB4-4C59-935C-1698D2CDB5C4Q33931959-53E05DD2-4F1E-4D46-9219-294A8EC709E8Q34122185-1AE9AAF3-40D7-49D3-8009-654022FD1FC0Q34243934-5DB0ADD7-5D62-44CD-920D-34A7B61912D1Q34359241-BE909481-EFCC-4521-A417-E1E760B06321Q34515293-43128B76-64D7-418A-9075-6DAC5714F80AQ34544211-9D285E4D-A58C-4C65-8680-323B7C0295FEQ34782463-CE2E51D5-E896-42F1-9075-3D6D155E46EEQ35044581-3980EA4B-FD1F-4FDD-BB71-A28B8342650DQ35156133-F6C03BA3-B378-44C2-9329-13A0E193803FQ35209385-EC5D09C8-D51F-4413-815C-C3E2CC5F7335Q35683195-ECC23B85-D20F-4165-A5A5-784AB1ADEBC2Q35747595-E91B22FA-C6F3-47FD-AB1A-FA275B9B1E0DQ35868064-5F57D8BA-35E7-43EF-9E12-A2B0A90ECD2BQ35871276-EA4E4B1E-04FA-42A5-93E9-182F94549AE6Q36225533-5CA51E77-F43D-479C-A432-E03BE6C135AFQ36336040-7B90D599-DC91-4ADB-B6D5-2138037301F1Q36348142-332539CC-539B-463A-9435-9BA9BCA91F6BQ36429565-3B4C07AC-595F-4BF7-B7D8-82BD76D2F89DQ36437285-06832262-55BF-4F6B-BE85-CF459523CC1AQ36634753-09EF5247-8377-47BC-BF3E-ABC687212470Q36644443-54E02804-7B28-4A7A-B797-97DDACF7E6AEQ36666554-B91C4DBF-B5C8-43DA-ACC3-F6E577AEBC87Q36688898-8D80A5EF-4A7B-4224-B30E-76E6BF1DAE30Q36759698-E0DE4815-0CDD-4C5D-B5DD-7D6CCC4222E0Q37002569-644A1610-08DD-41D8-AA2A-310E92BB91DBQ37252864-A87A0A47-DBCB-4904-B407-4EA7B6E684C2Q37348467-860BBC71-BAC1-4694-9162-878FB8798EF4Q37426718-D3D1BF2B-B6E0-4247-A79B-5829093B2C1FQ37682897-1D380940-9F53-492B-8B99-354744BF5D78Q39645119-817801D9-CB55-4BB6-BD49-FBA4BA5385E7Q40147969-4A47BB48-D8E8-419A-BA74-BDB573BB7C2D
P50
description
kinderarts
@nl
researcher
@en
հետազոտող
@hy
name
Steven L. Zeichner
@ast
Steven L. Zeichner
@en
Steven L. Zeichner
@es
Steven L. Zeichner
@nl
type
label
Steven L. Zeichner
@ast
Steven L. Zeichner
@en
Steven L. Zeichner
@es
Steven L. Zeichner
@nl
altLabel
S L Zeichner
@en
S Zeichner
@en
S. L. Zeichner
@en
S. Zeichner
@en
Steven L Zeichner
@en
Steven Zeichner
@en
Zeichner S
@en
Zeichner S. L.
@en
Zeichner S.
@en
Zeichner SL
@en
prefLabel
Steven L. Zeichner
@ast
Steven L. Zeichner
@en
Steven L. Zeichner
@es
Steven L. Zeichner
@nl
P101
P106
P21
P31
P496
0000-0002-8922-9260